Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

   22,000      
Direct Value   $6,950,507    

Indirect Value

   $160,840      
Total Shares   315,421      
Total Value   $7,111,347      


Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $1,090,139 Biocryst Pharmaceuticals Inc $409,170 Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $1,090,139 Biocryst Pharmaceuticals Inc $409,170
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    5    

     Stock price went up :
    1   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   0.0   
   1.5   
     Percentage Gain/Loss :
   -23.4%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2024-05-24 63,339 2024-05-24 2,500    Premium*  
* Premium Members only  

Records found :    170         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-08 4 S $22.11 $532,526 D/D (24,090) 19,855 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-08 4 OE $7.16 $172,484 D/D 24,090 55,361 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-04-30 4 A $11.64 $17,827 D/D 1,532 21,387 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-05-12 4 A $0.00 $0 D/D 11,200 32,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-05-22 4 OE $0.00 $0 D/D 2,500 35,087 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-06-07 4 OE $0.00 $0 D/D 2,500 37,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-09-08 4 S $22.00 $770,000 D/D (35,000) 37,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-09-08 4 OE $11.74 $410,900 D/D 35,000 72,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-10-29 4 A $11.64 $3,421 D/D 294 37,881 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.75 $206,000 D/D (8,000) 29,881 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 OE $14.39 $7,195 D/D 500 30,381 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.80 $12,900 D/D (500) 61,256 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-18 4 S $25.87 $811,546 D/D (31,375) 29,881 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-18 4 OE $14.39 $451,486 D/D 31,375 61,756 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-04-29 4 A $11.64 $18,583 D/D 1,597 31,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-03 4 OE $17.33 $178,690 D/D 10,311 41,789 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-03 4 S $27.15 $279,895 D/D (10,311) 31,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-12 4 A $0.00 $0 D/D 10,000 41,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-20 4 OE $0.00 $0 D/D 2,500 43,978 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-25 4 S $27.00 $247,779 D/D (9,177) 43,978 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-25 4 OE $17.33 $159,037 D/D 9,177 53,155 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-26 4 OE $17.33 $702,073 D/D 40,512 84,490 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-26 4 S $27.00 $1,093,828 D/D (40,512) 43,978 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-06-07 4 OE $0.00 $0 D/D 2,500 46,478 0 -
  170  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us